Matches in SemOpenAlex for { <https://semopenalex.org/work/W202016622> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W202016622 endingPage "100" @default.
- W202016622 startingPage "97" @default.
- W202016622 abstract "None of the approved immunomodulatory drugs in adults Multiple Sclerosis (MS) patients have been officially approved for the pediatric patients and are currently used off-label in this population. In this study, we evaluated the effectiveness and tolerability of intramuscular interferon beta1-a (Avonex(®)) and subcutaneously injected interferon beta1-b (Betaferon(®)) in children with definite relapsing-remitting MS (RRMS). Thirteen patients aged younger than 16, who were recently diagnosed with definite RRMS according to the McDonald's criteria, were enrolled in this study. Six patients were treated with Avonex(®) 30 μg, intramuscularly every week, and seven patients were treated with Betaferon(®) 250 μg, subcutaneously every other day. All patients were treated with adult doses; initially interferon-beta was prescribed with half dose, and it was increased to full adult dose steadily. Eleven girls and two boys, mean (SD) age of 14.7 (1.9) years, were studied. Following nine months of using interferon-beta, nine patients (69.2%) had no relapses and the remaining four, experienced only one relapse. The mean EDSS score was decreased significantly after the study period. The present study provides reasonable data for the use of interferon-beta in Pediatric MS due to lack of short-term complications and safety. Studies with larger sample size and longer follow up duration are required to shed light on the long term impact of the interferon-beta therapy in children." @default.
- W202016622 created "2016-06-24" @default.
- W202016622 creator A5001360175 @default.
- W202016622 creator A5028056356 @default.
- W202016622 creator A5033715120 @default.
- W202016622 creator A5039203448 @default.
- W202016622 creator A5042620953 @default.
- W202016622 creator A5042776283 @default.
- W202016622 creator A5051078947 @default.
- W202016622 creator A5089214258 @default.
- W202016622 date "2012-01-01" @default.
- W202016622 modified "2023-09-23" @default.
- W202016622 title "Interferon-beta in pediatric multiple sclerosis patients: safety in short-term prescription." @default.
- W202016622 cites W1991230604 @default.
- W202016622 cites W2001956066 @default.
- W202016622 cites W2012365353 @default.
- W202016622 cites W2026162142 @default.
- W202016622 cites W2038750204 @default.
- W202016622 cites W2040338159 @default.
- W202016622 cites W2042135359 @default.
- W202016622 cites W2063614302 @default.
- W202016622 cites W2075512998 @default.
- W202016622 cites W2080025109 @default.
- W202016622 cites W2095300907 @default.
- W202016622 cites W2128791454 @default.
- W202016622 cites W2152064198 @default.
- W202016622 cites W2152959293 @default.
- W202016622 cites W2916040650 @default.
- W202016622 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22359077" @default.
- W202016622 hasPublicationYear "2012" @default.
- W202016622 type Work @default.
- W202016622 sameAs 202016622 @default.
- W202016622 citedByCount "2" @default.
- W202016622 countsByYear W2020166222017 @default.
- W202016622 countsByYear W2020166222022 @default.
- W202016622 crossrefType "journal-article" @default.
- W202016622 hasAuthorship W202016622A5001360175 @default.
- W202016622 hasAuthorship W202016622A5028056356 @default.
- W202016622 hasAuthorship W202016622A5033715120 @default.
- W202016622 hasAuthorship W202016622A5039203448 @default.
- W202016622 hasAuthorship W202016622A5042620953 @default.
- W202016622 hasAuthorship W202016622A5042776283 @default.
- W202016622 hasAuthorship W202016622A5051078947 @default.
- W202016622 hasAuthorship W202016622A5089214258 @default.
- W202016622 hasConcept C126322002 @default.
- W202016622 hasConcept C187212893 @default.
- W202016622 hasConcept C197934379 @default.
- W202016622 hasConcept C203014093 @default.
- W202016622 hasConcept C2426938 @default.
- W202016622 hasConcept C2778375690 @default.
- W202016622 hasConcept C2780640218 @default.
- W202016622 hasConcept C2908647359 @default.
- W202016622 hasConcept C2908698914 @default.
- W202016622 hasConcept C2994247566 @default.
- W202016622 hasConcept C71924100 @default.
- W202016622 hasConcept C98274493 @default.
- W202016622 hasConcept C99454951 @default.
- W202016622 hasConceptScore W202016622C126322002 @default.
- W202016622 hasConceptScore W202016622C187212893 @default.
- W202016622 hasConceptScore W202016622C197934379 @default.
- W202016622 hasConceptScore W202016622C203014093 @default.
- W202016622 hasConceptScore W202016622C2426938 @default.
- W202016622 hasConceptScore W202016622C2778375690 @default.
- W202016622 hasConceptScore W202016622C2780640218 @default.
- W202016622 hasConceptScore W202016622C2908647359 @default.
- W202016622 hasConceptScore W202016622C2908698914 @default.
- W202016622 hasConceptScore W202016622C2994247566 @default.
- W202016622 hasConceptScore W202016622C71924100 @default.
- W202016622 hasConceptScore W202016622C98274493 @default.
- W202016622 hasConceptScore W202016622C99454951 @default.
- W202016622 hasIssue "2" @default.
- W202016622 hasLocation W2020166221 @default.
- W202016622 hasOpenAccess W202016622 @default.
- W202016622 hasPrimaryLocation W2020166221 @default.
- W202016622 hasRelatedWork W1983148737 @default.
- W202016622 hasRelatedWork W2000949921 @default.
- W202016622 hasRelatedWork W2083435766 @default.
- W202016622 hasRelatedWork W2160870257 @default.
- W202016622 hasRelatedWork W2335561239 @default.
- W202016622 hasRelatedWork W2341336326 @default.
- W202016622 hasRelatedWork W2401744381 @default.
- W202016622 hasRelatedWork W2797418446 @default.
- W202016622 hasRelatedWork W2982358067 @default.
- W202016622 hasRelatedWork W4247429833 @default.
- W202016622 hasVolume "50" @default.
- W202016622 isParatext "false" @default.
- W202016622 isRetracted "false" @default.
- W202016622 magId "202016622" @default.
- W202016622 workType "article" @default.